DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans

Radiotherapy and Oncology

Volumn 87, Issue 1, 2008, Pages 110-115

  Pasciuti, Katia ^a   Iaccarino, Giuseppe ^a   Soriani, Antonella ^a   Bruzzaniti, Vicente ^a   Marzi, Simona ^a   Gomellini, Sara ^b   Arcangeli, Stefano ^b   Benassi, Marcello ^a   Landoni, Valeria ^a  

^a Laboratory of Medical Physics and Expert Systems

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Brain metastases; Dynamic conformal arcs; Intensity modulated stereotactic radiotherapy; Stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; COMPUTER ASSISTED RADIOTHERAPY; DOSE VOLUME HISTOGRAM; FEMALE; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; STEREOTACTIC TREATMENT; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; IMMOBILIZATION; MALE; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 41949112303     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.019     Document Type: Article

References (25)

1. Jyothirmayi R., Saran F.H., Jalai R., Perks J., et al. Stereotactic radiotherapy for solitary brain metastases. Clin Oncol 13 (2001) 228-234
2. Curry W.T., Cosgrove G.R., Hochberg F.H., et al. Stereotactic interstitial radiosurgery for cerebral metastases. J Neurosurg 103 (2005) 630-635
3. Grzadziel A., Grosu A.L., Kneschaurek P., et al. Three-dimensional conformal versus intensity-modulated radiotherapy dose planning in stereotactic radiotherapy: application of standard quality parameters for plan evaluation. Int J Radiat Oncol Biol Phys 66 (2006) S87-S94
4. Ding M., Newman F., Kavanagh B.D., et al. Comparative dosimetric study of three-dimensional conformal, dynamic conformal arc, and Intensity-modulated radiotherapy for brain tumor treatment using novalis system. Int J Radiat Oncol Biol Phys 66 (2006) S82-S86
5. Jochen W., Michael F., and Klaus B. CT simulation in stereotactic brain radiotherapy-analysis of isocenter reproducibility with mask fixation. Radiother Oncol 45 (1997) 83-88
6. Lee F.-T., Tessa L., and Jaywant S.M. Immobilization in stereotactic radiotherapy: the head and neck localizer frame. Med Dosim 26 (2001) 267-273
7. Theodorou K., Kappas C., Tsokas C., et al. A new non-invasive and relocable immobilization frame for fractionated stereotactic radiotherapy. Radiother Oncol 47 (1998) 313-317
8. Treuer H., Kocher M., Hoevels M., et al. Impact of target point deviations on control and complication probabilities in stereotactic radiosurgery of AVMs and metastases. Radiother Oncol 81 (2006) 25-32
9. Jones B., Dale R.G., Deehan C., et al. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol 13 (2001) 71-81
10. Warkentin B., Stavrev P., Stavreva N., et al. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. J Appl Clin Med Phys 5 (2004) 50-63
11. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
12. Landoni V. Radiobiological considerations in the choice of the reference dose level from DVHs Seventh International Conference on Dose, Time and Fractionation in Radiation Oncology. AAPM Symp Proc 14 (2006) 96-106
13. Begnozzi L., Gentile F.P., Chiatti L., et al. Study on the reference dose level in radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 28 (1994) 515-522
14. Higgins P.D., Gerbi B.J., Macedon M., et al. Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma. J Appl Clin Med Phys 7 (2006) 9-17
15. Wu Q.R.J., Wessels B.W., Einstein D.B., et al. Quality of coverage: conformity measures for stereotactic radiosurgery. J Appl Clin Med Phys 4 (2003) 374-381
16. Smith V., Verhey L., and Serago C.F. Comparison of radiosurgery treatment modalities based on complication and control probabilities. Int J Radiat Oncol Biol Phys 40 (1998) 507-513
17. Vogelbaum M.A., Angelov L., Lee S.Y., et al. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104 (2006) 907-912
18. Kavanagh B.D., Timmerman R.D., Benedict S.H., et al. How should we describe the radiobiological effect of extracranial stereotactic radiosurgery: equivalent uniform dose or tumor control probability?. Med Phys 30 (2003) 321-324
19. Yorke E.D. Modelling the effects of inhomogeneous dose distributions in normal tissues. Semin Radiat Oncol 3 (2001) 197-209
20. Andrewa D.W., Scott C.B., and Sperduto P.W. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 9422 (2004) 1665-1672
21. Kumar A.J., Leeds N.E., and Van Tassel P. Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of brain after treatment. Radiology 217 (2002) 377-384
22. Karlsson B., Lax I., and Soderman M. Factors influencing the risk for complications following gamma knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol 43 (1997) 275-280
23. Chin L.S., Ma L., and DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94 (2001) 899-904
24. Loeffler J.S., Alexander III E., et al. Radiosurgery as part of the initial management of patients with malignant glioma. J Clin Oncol 10 (1992) 1379-1385
25. Shaw E., Scott C., et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol 90-05. Int J Radiat Oncol Biol Phys 34 (1996) 647-654